-- U.S. RESEARCH ROUNDUP-Salesforce.com, Chesapeake Energy, Gentiva Health, Dick's Sporting Goods 
-- 
-- Wed May 21, 2014 05:44AM EDT
-- None



May 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Salesforce and Dick's Sporting on Wednesday.

HIGHLIGHTS * Salesforce <CRM.N>: Macquarie, Barclays, others cut target price  * Dick's Sporting Goods <DKS.N>: Credit Suisse, Goldman Sachs downgrade the stock * Enable Midstream Partners <ENBL.N>: Barclays starts with overweight; price target of $28 * Gentiva Health <GTIV.O>: Piper Jaffray cuts to neutral from overweight  * Apollo Investment <AINV.O>: JMP Securities raises to market outperform from market perform  Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.* Analog Devices <ADI.O>: Deutsche Bank raises target price to $51 from $47; rating hold * Analog Devices <ADI.O>: Jefferies raises target price to $60 from $59; rating buy * Analog Devices <ADI.O>: Nomura raises target price to $53 from $50; rating neutral  * Apollo Investment <AINV.O>: JMP Securities raises to market outperform from market perform * Apollo Investment <AINV.O>: KBW raises target price to $9 from $8.50 * Bazaarvoice <BV.O>: Goldman Sachs cuts price target to $7 from $8; rating neutral * Benefitfocus Inc <BNFT.O>: Goldman Sachs cuts price target to $50 from $64; rating buy  * Brown & Brown <BRO.N>: Macquarie cuts price target by $1 to $32; rating neutral * Centerpoint Energy <CNP.N>: Barclays re-instates coverage with an equal weight rating  * Chesapeake Energy <CHK.N>: Oppenheimer raises price target to $35 from $30; outperform  * Dick's Sporting Goods <DKS.N>: Barclays cuts target to $50 from $60; rating overweight  * Dick's Sporting Goods <DKS.N>: Credit Suisse cuts to neutral from outperform * Dick's Sporting Goods <DKS.N>: Credit Suisse cuts price target to $49 from $65  * Dick's Sporting Goods <DKS.N>: Goldman Sachs cuts to neutral from buy * Dick's Sporting Goods <DKS.N>: Goldman Sachs removes from Americas Conviction-Buy List  * Dick's Sporting Goods <DKS.N>: Susquehanna cuts target to $51 from $65; rating positive  * Edwards Lifesciences <EW.N>: Canaccord Genuity raises target to $96 from $86; rating buy * Enable Midstream Partners <ENBL.N>: Barclays starts with overweight; price target of $28 * Enable Midstream Partners <ENBL.N>: Credit Suisse starts with outperform; price target $27 * Enable Midstream Partners <ENBL.N>: Goldman starts with neutral; price target $24 * Enable Midstream Partners <ENBL.N>: JP Morgan starts with neutral; price target $26  * Enable Midstream Partners <ENBL.N>: UBS starts with buy; target price $27  * Evercore Partners <EVR.N>: JMP Securities raises to market outperform from market perform  * Gentiva Health <GTIV.O>: Piper Jaffray cuts to neutral from overweight * Gentiva Health <GTIV.O>: Piper Jaffray raises target price to $14 from $11 * Haemonetics <HAE.N>: Jefferies raises price target to $38 from $36; rating buy * Hhgregg <HGG.N>: Jefferies raises target price to $8.50 from $8; rating hold  * Home Properties <HME.N>: Barclays raises target price to $62 from $61; rating equal weight * Leju Holdings <LEJU.N>: Macquarie raises target price to $16; keeps outperform rating * Liquid Holdings <LIQD.O>: JMP Securities starts with market outperform; target price $2.25 * Lombard Medical Inc <EVAR.O>: Jefferies starts with buy; price target $11  * Mallinckrodt <MNK.N>: Leerink raises price target to $90 from $82; rating market perform * Marketo Inc <MKTO.O>: Goldman Sachs removes from Conviction Buy-List  * Medallion Financial <TAXI.O>: KBW cuts price target to $15 from $15.50; market perform  * NOW <DNOW_w.N>: JP Morgan starts with overweight rating; price target $39 * OGE Energy Corp <OGE.N>: Barclays re-instates with overweight rating  * Ophthotech <OPHT.O>: Morgan Stanley raises target price to $99 from $79; rating overweight * Perfect World Co <PWRD.O>: Barclays cuts target price to $23 from $25; rating equal weight * Salesforce.com <CRM.N>: Barclays cuts target price to $63 from $69; rating overweight * Salesforce.com <CRM.N>: Canaccord Genuity cuts target price to $65 from $80; rating buy  * Salesforce.com <CRM.N>: Macquarie cuts target price to $65 from $75; rating outperform  * Salesforce.com <CRM.N>: Pivotal Research cuts target price to $73 from $74; rating buy  * Stage Stores <SSI.N>: Nomura cuts target price to $20 from $24; rating neutral  * SBA Communications <SBAC.O>: Jefferies raises price target to $115 from $100; rating buy  * Staples <SPLS.O>: JP Morgan cuts target price to $11 from $12; rating neutral * Tableau Software <DATA.N>: Goldman Sachs cuts price target to $85 from $115; rating buy  * Telecom Argentina <TEO.N>: Morgan Stanley raises target to $18 from $17; equal weight  * Thermo Fisher Scientific <TMO.N>: Cowen and Company raises price target to $135 from $125 * TJX <TJX.N>: Nomura cuts target price to $65 from $67; rating buy * Ultimate Software <ULTI.O>: Goldman Sachs cuts target price to $117 from $144 * Valeant Pharmaceuticals <VRX.N>: CIBC starts with sector outperformer; price target $160  * Wesco Aircraft Holdings <WAIR.N>: Jefferies cuts price target to $23 from $25; rating hold